These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
635 related articles for article (PubMed ID: 10933942)
1. Evaluation of the biodistribution, persistence, toxicity, and potential of germ-line transmission of a replication-competent human adenovirus following intraprostatic administration in the mouse. Paielli DL; Wing MS; Rogulski KR; Gilbert JD; Kolozsvary A; Kim JH; Hughes J; Schnell M; Thompson T; Freytag SO Mol Ther; 2000 Mar; 1(3):263-74. PubMed ID: 10933942 [TBL] [Abstract][Full Text] [Related]
2. Phase I study of replication-competent adenovirus-mediated double suicide gene therapy for the treatment of locally recurrent prostate cancer. Freytag SO; Khil M; Stricker H; Peabody J; Menon M; DePeralta-Venturina M; Nafziger D; Pegg J; Paielli D; Brown S; Barton K; Lu M; Aguilar-Cordova E; Kim JH Cancer Res; 2002 Sep; 62(17):4968-76. PubMed ID: 12208748 [TBL] [Abstract][Full Text] [Related]
3. No evidence for germ-line transmission following prenatal and early postnatal AAV-mediated gene delivery. Jakob M; Mühle C; Park J; Weiss S; Waddington S; Schneider H J Gene Med; 2005 May; 7(5):630-7. PubMed ID: 15693035 [TBL] [Abstract][Full Text] [Related]
4. Second-generation replication-competent oncolytic adenovirus armed with improved suicide genes and ADP gene demonstrates greater efficacy without increased toxicity. Barton KN; Paielli D; Zhang Y; Koul S; Brown SL; Lu M; Seely J; Kim JH; Freytag SO Mol Ther; 2006 Feb; 13(2):347-56. PubMed ID: 16290236 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and toxicity of replication-competent adenovirus-mediated double suicide gene therapy in combination with radiation therapy in an orthotopic mouse prostate cancer model. Freytag SO; Paielli D; Wing M; Rogulski K; Brown S; Kolozsvary A; Seely J; Barton K; Dragovic A; Kim JH Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):873-85. PubMed ID: 12377341 [TBL] [Abstract][Full Text] [Related]
6. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase. Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394 [TBL] [Abstract][Full Text] [Related]
7. A novel ex vivo model system for evaluation of conditionally replicative adenoviruses therapeutic efficacy and toxicity. Kirby TO; Rivera A; Rein D; Wang M; Ulasov I; Breidenbach M; Kataram M; Contreras JL; Krumdieck C; Yamamoto M; Rots MG; Haisma HJ; Alvarez RD; Mahasreshti PJ; Curiel DT Clin Cancer Res; 2004 Dec; 10(24):8697-703. PubMed ID: 15623655 [TBL] [Abstract][Full Text] [Related]
8. Double suicide gene therapy augments the antitumor activity of a replication-competent lytic adenovirus through enhanced cytotoxicity and radiosensitization. Rogulski KR; Wing MS; Paielli DL; Gilbert JD; Kim JH; Freytag SO Hum Gene Ther; 2000 Jan; 11(1):67-76. PubMed ID: 10646640 [TBL] [Abstract][Full Text] [Related]
9. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters. Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218 [TBL] [Abstract][Full Text] [Related]
10. No evidence of germ-line transmission by adenovirus-mediated gene transfer to mouse testes. Kojima Y; Hayashi Y; Kurokawa S; Mizuno K; Sasaki S; Kohri K Fertil Steril; 2008 May; 89(5 Suppl):1448-54. PubMed ID: 17624347 [TBL] [Abstract][Full Text] [Related]
11. Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs. Wildner O; Hoffmann D; Jogler C; Uberla K Cancer Gene Ther; 2003 Oct; 10(10):791-802. PubMed ID: 14502232 [TBL] [Abstract][Full Text] [Related]
12. The role of the E1B 55 kDa gene product in oncolytic adenoviral vectors expressing herpes simplex virus-tk: assessment of antitumor efficacy and toxicity. Wildner O; Morris JC Cancer Res; 2000 Aug; 60(15):4167-74. PubMed ID: 10945625 [TBL] [Abstract][Full Text] [Related]
13. A fiber-modified, secretory leukoprotease inhibitor promoter-based conditionally replicating adenovirus for treatment of ovarian cancer. Rein DT; Breidenbach M; Kirby TO; Han T; Siegal GP; Bauerschmitz GJ; Wang M; Nettelbeck DM; Tsuruta Y; Yamamoto M; Dall P; Hemminki A; Curiel DT Clin Cancer Res; 2005 Feb; 11(3):1327-35. PubMed ID: 15709205 [TBL] [Abstract][Full Text] [Related]
14. [Adenovirus-mediated double suicide gene therapy for experimental bladder carcinoma]. Tan WL; Xie Y; Wu YD; Zhu WH; Zheng SB Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):594-7. PubMed ID: 16762858 [TBL] [Abstract][Full Text] [Related]
15. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice. Marsman D Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194 [TBL] [Abstract][Full Text] [Related]
16. Local inflammatory response and vector spread after direct intraprostatic injection of a recombinant adenovirus containing the herpes simplex virus thymidine kinase gene and ganciclovir therapy in mice. Timme TL; Hall SJ; Barrios R; Woo SL; Aguilar-Cordova E; Thompson TC Cancer Gene Ther; 1998; 5(2):74-82. PubMed ID: 9570298 [TBL] [Abstract][Full Text] [Related]
17. [Adenovirus-mediated double suicide gene selectively kills breast cancer MCF-7 cells in vitro]. Kong H; Huang ZH; Li Q; Yang LC; Yu JL; Li Z Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):907-10. PubMed ID: 18583225 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of hepatocellular carcinoma with a novel gene-viral therapeutic system CNHK300-murine endostatin]. Li GC; Nie MM; Yang JM; Su CQ; Sun LC; Qian YZ; Sham J; Fang GE; Wu MC; Qian QJ Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):943-8. PubMed ID: 15329284 [TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477 [TBL] [Abstract][Full Text] [Related]
20. Therapy of peritoneal carcinomatosis from colon cancer with oncolytic adenoviruses. Wildner O; Morris JC J Gene Med; 2000; 2(5):353-60. PubMed ID: 11045429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]